Last updated: October 7, 2023
Sponsor: The Affiliated Hospital of Qingdao University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gastric Cancer
Stomach Cancer
Digestive System Neoplasms
Treatment
Radical Gastric Cancer Surgery
Clinical Study ID
NCT06076265
SMOG01
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Gastric adenocarcinoma confirmed by preoperative pathology
- Endoscopic and CT/MRI enhanced examination confirmed that cT1-4aN0-3M0 has thepossibility of resection
- To undergo radical gastrectomy (laparoscopic or robotic) under general anesthesia+/-epidural anesthesia (carbon dioxide pneumoperitoneum)
- Willing and able to comply with the research protocol
- Reach a written consent agreement before registration, and fully realize the right towithdraw from the study at any time without any loss
Exclusion
Exclusion Criteria:
- Urgent surgery is required due to tumor emergencies (such as bleeding, perforation,and obstruction)
- Extensive peritoneal metastasis can be seen during intraoperative exploration
- Other diseases requiring simultaneous surgery
- Patients with ascites
- Pregnancy
Study Design
Total Participants: 80
Treatment Group(s): 1
Primary Treatment: Radical Gastric Cancer Surgery
Phase:
Study Start date:
December 01, 2022
Estimated Completion Date:
October 31, 2023
Study Description
Connect with a study center
The Affiliated Hospital of Qingdao University
Qingdao, Shandong
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.